The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data - Concepedia

Concepedia

Publication | Open Access

The efficacy and safety of weekly 35-mg risedronate dosing regimen for Chinese postmenopausal women with osteoporosis or osteopenia: 1-year data

DOI Full Paper Access

14

Citations

11

References

2015

Year

Jie‐Mei Gu, Li Wang, Hua Lin, Decai Chen, Hai Tang, Xiaolan Jin, Weibo Xia, Yun-qiu Hu, Wen‐Zhen Fu, Jin‐Wei He,

Acta Pharmacologica Sinica

Bone DiseaseBone HealthChinese Postmenopausal WomenPharmacotherapyMenopauseWeekly 35-Mg Risedronate1-Year DataMedicineOsteoporosisOrthopaedic SurgeryWomen's Health

References

	Year	Citations

Page 1

Page 1